Response Biomedical

About:

Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests.

Website: http://responsebio.com

Top Investors: Silicon Valley Bank

Description:

Response Biomedical Corp. ("Response") (TSX: RBM, OTCBB: RPBIF) develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, Canada, for use on the RAMP® Platform. The RAMP® Platform is sold worldwide and includes a variety of testing applications in the clinical, infectious disease, biodefense and environmental arenas. The RAMP® Platform provides laboratory quality results with the speed, precision and accuracy that many hospitals expect of their central lab systems. It is ideally suited for both point of care testing and laboratory use.

Total Funding Amount:

$21.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

1992-01-01

Contact Email:

customersupport(AT)responsebio.com

Founders:

Barbara Kinnaird

Number of Employees:

51-100

Last Funding Date:

2014-02-12

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai